Yamashita Dennis
SEC insider (Form 3/4/5 filer). CIK 0002039412. Chief Scientific Officer at Kintara Therapeutics, Inc. (KTRA). 1 reported Form 4/5 transaction since Sep 2024; latest on Oct 18, 2024. Located in TAMPA, FL.
Companies Yamashita Dennis has filed insider reports for
- Kintara Therapeutics, Inc. (KTRA): Officer, Chief Scientific Officer
Yamashita Dennis
CIK: 0002039412
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KTRA
Kintara Therapeutics, Inc.
Officer